- Home
- CRVO vs CATO Comparison
CRVO vs CATO Comparison
Compare CRVO & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- CATO
- Stock Information
- Founded
- CRVO 2001
- CATO 1946
- Country
- CRVO United States
- CATO United States
- Employees
- CRVO N/A
- CATO N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- CATO Clothing/Shoe/Accessory Stores
- Sector
- CRVO Health Care
- CATO Consumer Discretionary
- Exchange
- CRVO Nasdaq
- CATO Nasdaq
- Market Cap
- CRVO 67.4M
- CATO 59.2M
- IPO Year
- CRVO N/A
- CATO N/A
- Fundamental
- Price
- CRVO $5.56
- CATO $2.87
- Analyst Decision
- CRVO Strong Buy
- CATO
- Analyst Count
- CRVO 8
- CATO 0
- Target Price
- CRVO $25.57
- CATO N/A
- AVG Volume (30 Days)
- CRVO 137.9K
- CATO 43.0K
- Earning Date
- CRVO 08-08-2025
- CATO 08-21-2025
- Dividend Yield
- CRVO N/A
- CATO 6.11%
- EPS Growth
- CRVO N/A
- CATO N/A
- EPS
- CRVO N/A
- CATO N/A
- Revenue
- CRVO $9,308,215.00
- CATO $642,949,000.00
- Revenue This Year
- CRVO N/A
- CATO N/A
- Revenue Next Year
- CRVO N/A
- CATO N/A
- P/E Ratio
- CRVO N/A
- CATO N/A
- Revenue Growth
- CRVO 15.14
- CATO N/A
- 52 Week Low
- CRVO $1.80
- CATO $2.19
- 52 Week High
- CRVO $20.63
- CATO $6.70
- Technical
- Relative Strength Index (RSI)
- CRVO 30.87
- CATO 53.03
- Support Level
- CRVO $6.31
- CATO $2.73
- Resistance Level
- CRVO $7.20
- CATO $2.99
- Average True Range (ATR)
- CRVO 0.53
- CATO 0.18
- MACD
- CRVO -0.10
- CATO -0.02
- Stochastic Oscillator
- CRVO 0.00
- CATO 30.14
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.